img

Global Gastrointestinal Disorder Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gastrointestinal Disorder Therapeutics Market Insights, Forecast to 2034

Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.
Market Analysis and InsightsGlobal Gastrointestinal Disorder Therapeutics Market
Global Gastrointestinal Disorder Therapeutics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Gastrointestinal Disorder Therapeutics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Gastrointestinal Disorder Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Gastrointestinal Disorder Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma
Segment by Type
Irritable Bowel Syndrome (IBS)
Chronic Constipation (CC)
Ulcerative Colitis (UC)

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gastrointestinal Disorder Therapeutics introduction, etc. Gastrointestinal Disorder Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Gastrointestinal Disorder Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Irritable Bowel Syndrome (IBS)
1.2.3 Chronic Constipation (CC)
1.2.4 Ulcerative Colitis (UC)
1.3 Market by Application
1.3.1 Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Disorder Therapeutics Market Perspective (2018-2033)
2.2 Global Gastrointestinal Disorder Therapeutics Growth Trends by Region
2.2.1 Gastrointestinal Disorder Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastrointestinal Disorder Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Disorder Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Gastrointestinal Disorder Therapeutics Market Dynamics
2.3.1 Gastrointestinal Disorder Therapeutics Industry Trends
2.3.2 Gastrointestinal Disorder Therapeutics Market Drivers
2.3.3 Gastrointestinal Disorder Therapeutics Market Challenges
2.3.4 Gastrointestinal Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gastrointestinal Disorder Therapeutics by Players
3.1.1 Global Gastrointestinal Disorder Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gastrointestinal Disorder Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Disorder Therapeutics Revenue in 2022
3.5 Global Key Players of Gastrointestinal Disorder Therapeutics Head office and Area Served
3.6 Global Key Players of Gastrointestinal Disorder Therapeutics, Product and Application
3.7 Global Key Players of Gastrointestinal Disorder Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Disorder Therapeutics Breakdown Data by Type
4.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2024-2033)
5 Gastrointestinal Disorder Therapeutics Breakdown Data by Application
5.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
6.2 North America Gastrointestinal Disorder Therapeutics Market Size by Type
6.2.1 North America Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
6.3 North America Gastrointestinal Disorder Therapeutics Market Size by Application
6.3.1 North America Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
6.4 North America Gastrointestinal Disorder Therapeutics Market Size by Country
6.4.1 North America Gastrointestinal Disorder Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
7.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Type
7.2.1 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Application
7.3.1 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
7.4 Europe Gastrointestinal Disorder Therapeutics Market Size by Country
7.4.1 Europe Gastrointestinal Disorder Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
8.2 China Gastrointestinal Disorder Therapeutics Market Size by Type
8.2.1 China Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023)
8.2.2 China Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033)
8.2.3 China Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
8.3 China Gastrointestinal Disorder Therapeutics Market Size by Application
8.3.1 China Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023)
8.3.2 China Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033)
8.3.3 China Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
9.2 Asia Gastrointestinal Disorder Therapeutics Market Size by Type
9.2.1 Asia Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
9.3 Asia Gastrointestinal Disorder Therapeutics Market Size by Application
9.3.1 Asia Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
9.4 Asia Gastrointestinal Disorder Therapeutics Market Size by Region
9.4.1 Asia Gastrointestinal Disorder Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Gastrointestinal Disorder Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Gastrointestinal Disorder Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.1.5 AstraZeneca Recent Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Introduction
11.2.4 Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.2.5 Takeda Pharmaceutical Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.3.5 Johnson & Johnson Recent Developments
11.4 Eisai
11.4.1 Eisai Company Details
11.4.2 Eisai Business Overview
11.4.3 Eisai Gastrointestinal Disorder Therapeutics Introduction
11.4.4 Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.4.5 Eisai Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Introduction
11.5.4 Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.5.5 Abbott Laboratories Recent Developments
11.6 Salix Pharmaceuticals
11.6.1 Salix Pharmaceuticals Company Details
11.6.2 Salix Pharmaceuticals Business Overview
11.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Introduction
11.6.4 Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.6.5 Salix Pharmaceuticals Recent Developments
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Introduction
11.7.4 Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.7.5 Bausch Health Recent Developments
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Gastrointestinal Disorder Therapeutics Introduction
11.8.4 Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.8.5 Allergan Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Gastrointestinal Disorder Therapeutics Introduction
11.9.4 Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.9.5 Bayer Recent Developments
11.10 UCB
11.10.1 UCB Company Details
11.10.2 UCB Business Overview
11.10.3 UCB Gastrointestinal Disorder Therapeutics Introduction
11.10.4 UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.10.5 UCB Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Gastrointestinal Disorder Therapeutics Introduction
11.11.4 AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.11.5 AbbVie Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Introduction
11.12.4 GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.12.5 GlaxoSmithKline Recent Developments
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Details
11.13.2 Astellas Pharma Business Overview
11.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Introduction
11.13.4 Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.13.5 Astellas Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Irritable Bowel Syndrome (IBS)
Table 3. Key Players of Chronic Constipation (CC)
Table 4. Key Players of Ulcerative Colitis (UC)
Table 5. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gastrointestinal Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gastrointestinal Disorder Therapeutics Market Share by Region (2018-2023)
Table 9. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gastrointestinal Disorder Therapeutics Market Share by Region (2024-2033)
Table 11. Gastrointestinal Disorder Therapeutics Market Trends
Table 12. Gastrointestinal Disorder Therapeutics Market Drivers
Table 13. Gastrointestinal Disorder Therapeutics Market Challenges
Table 14. Gastrointestinal Disorder Therapeutics Market Restraints
Table 15. Global Gastrointestinal Disorder Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gastrointestinal Disorder Therapeutics Revenue Share by Players (2018-2023)
Table 17. Global Top Gastrointestinal Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2022)
Table 18. Global Gastrointestinal Disorder Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Disorder Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Gastrointestinal Disorder Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Gastrointestinal Disorder Therapeutics, Product and Application
Table 22. Global Key Players of Gastrointestinal Disorder Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gastrointestinal Disorder Therapeutics Revenue Share by Application (2018-2023)
Table 30. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gastrointestinal Disorder Therapeutics Revenue Share by Application (2024-2033)
Table 32. North America Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Gastrointestinal Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Gastrointestinal Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Gastrointestinal Disorder Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Gastrointestinal Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Gastrointestinal Disorder Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Gastrointestinal Disorder Therapeutics Product
Table 67. AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 68. AstraZeneca Recent Developments
Table 69. Takeda Pharmaceutical Company Details
Table 70. Takeda Pharmaceutical Business Overview
Table 71. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product
Table 72. Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Takeda Pharmaceutical Recent Developments
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product
Table 77. Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Johnson & Johnson Recent Developments
Table 79. Eisai Company Details
Table 80. Eisai Business Overview
Table 81. Eisai Gastrointestinal Disorder Therapeutics Product
Table 82. Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Eisai Recent Developments
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product
Table 87. Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Abbott Laboratories Recent Developments
Table 89. Salix Pharmaceuticals Company Details
Table 90. Salix Pharmaceuticals Business Overview
Table 91. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product
Table 92. Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Salix Pharmaceuticals Recent Developments
Table 94. Bausch Health Company Details
Table 95. Bausch Health Business Overview
Table 96. Bausch Health Gastrointestinal Disorder Therapeutics Product
Table 97. Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 98. Bausch Health Recent Developments
Table 99. Allergan Company Details
Table 100. Allergan Business Overview
Table 101. Allergan Gastrointestinal Disorder Therapeutics Product
Table 102. Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 103. Allergan Recent Developments
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Gastrointestinal Disorder Therapeutics Product
Table 107. Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Bayer Recent Developments
Table 109. UCB Company Details
Table 110. UCB Business Overview
Table 111. UCB Gastrointestinal Disorder Therapeutics Product
Table 112. UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 113. UCB Recent Developments
Table 114. AbbVie Company Details
Table 115. AbbVie Business Overview
Table 116. AbbVie Gastrointestinal Disorder Therapeutics Product
Table 117. AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 118. AbbVie Recent Developments
Table 119. GlaxoSmithKline Company Details
Table 120. GlaxoSmithKline Business Overview
Table 121. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product
Table 122. GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 123. GlaxoSmithKline Recent Developments
Table 124. Astellas Pharma Company Details
Table 125. Astellas Pharma Business Overview
Table 126. Astellas Pharma Gastrointestinal Disorder Therapeutics Product
Table 127. Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Astellas Pharma Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Gastrointestinal Disorder Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Irritable Bowel Syndrome (IBS) Features
Figure 4. Chronic Constipation (CC) Features
Figure 5. Ulcerative Colitis (UC) Features
Figure 6. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Gastrointestinal Disorder Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Gastrointestinal Disorder Therapeutics Report Years Considered
Figure 12. Global Gastrointestinal Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Gastrointestinal Disorder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Gastrointestinal Disorder Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Gastrointestinal Disorder Therapeutics Market Share by Players in 2022
Figure 16. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2022
Figure 18. North America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
Figure 20. North America Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
Figure 21. North America Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 22. United States Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Gastrointestinal Disorder Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
Figure 26. Europe Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
Figure 27. Europe Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 28. Germany Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Gastrointestinal Disorder Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
Figure 36. China Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
Figure 37. Asia Gastrointestinal Disorder Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
Figure 39. Asia Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
Figure 40. Asia Gastrointestinal Disorder Therapeutics Market Share by Region (2018-2033)
Figure 41. Japan Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 51. Brazil Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 60. Eisai Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 61. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 62. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 63. Bausch Health Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 64. Allergan Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 65. Bayer Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 66. UCB Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 67. AbbVie Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 68. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 69. Astellas Pharma Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries